CNS Pharmaceuticals Inc (CNSP) Live Share Price, Invest From India

CNS Pharmaceuticals Inc Stock Performance

as on May 6, 2026 at 6:59 am IST

Day's Low
Day's High
$5.27
Day's Price Range
$7.30
$7.12
25.98%
Downside
2.53%
Upside
52 Week's Low
52 Week's High
$1.90
52-Week Price Range
$34.80
$7.12
73.31%
Downside
388.75%
Upside

CNS Pharmaceuticals Inc share price movements today

Previous Close: $7.84
Open: $5.67
Volume: 1.1M
Day's Low - High: $5.27 - $7.30
52 Week Low - High: $1.90 - $34.80

CNS Pharmaceuticals Inc Historical Returns

1 Month Return: + 208.19 %
3 Month Return: + 58.54 %
1 Year Return: -45.83 %
3 Year Return: -99.99 %
5 Year Return: -100 %

CNS Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check CNS Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.8M

EPS (TTM)

-3.67

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-16.0M

Revenue (TTM)

Profit Margin

0.00%

Return On Equity TTM

-296.30%

CNS Pharmaceuticals Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of CNS Pharmaceuticals Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
CNS Pharmaceuticals Inc	SELL	$5.8M	-100%	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$40.2B	127.94%	75.85	12.55%
Vertex Pharmaceuticals Inc	BUY	$107.9B	99.08%	25.18	32.94%
BeiGene, Ltd.	NA	$33.1B	NA	120.44	5.37%
Regeneron Pharmaceuticals Inc	BUY	$73.6B	40.83%	17.13	29.65%

Stock Returns calculator for CNS Pharmaceuticals Inc Stock including INR - Dollar returns

The CNS Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

CNS Pharmaceuticals Inc investment value today

Current value as on today

₹60,969

Returns

-₹39,031

(-39.03%)

Returns from CNS Pharmaceuticals Inc Stock

-₹46,061 (-46.06%)

Dollar Impact

₹7,030 (+7.03%)

Analyst Recommendation on CNS Pharmaceuticals Inc Stock

Based on 6 analysts

SELL

0.00%

Buy

50.00%

Hold

50.00%

Sell

Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for CNS Pharmaceuticals Inc. Average target price of $10

CNS Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on CNS Pharmaceuticals Inc.

What analysts predicted

28.8%UPSIDE

Target Price

$10

Current Price

$7.12

Analyzed by

6 Analysts

Target

$10.00

CNS Pharmaceuticals Inc target price $10, a slight upside of 28.8% compared to current price of $7.12. According to 6 analysts rating.

CNS Pharmaceuticals Inc Stock’s Investor Sentiment and Interest

Search interest for CNS Pharmaceuticals Inc Stock has increased by 653% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 6, 2026 to May 6, 2026

Change:653% versus previous 30 day period

CNS Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	-	-	0	-	-	0	0	-	-	-
Gross Profit	0	-	0	0	0	0	0	0	0	0
Operating Income	-4	-5	-3	-2	-5	-3	-4	-2	-3	-5
EBITDA	-4	-	-3	-2	-5	-3	-4	-2	-3	-5
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-4	-5	-3	-2	-5	-3	-4	-2	-3	-5
Income Tax Expense	0	-	0	0	-	-	-	-	-	-
Net Income	-4	-5	-3	-2	-5	-3	-4	-2	-3	-5
Net Profit Margin	0.00%	0.00%	-55717.51%	0.00%	0.00%	-101158.15%	-136984.71%	0.00%	0.00%	0.00%

CNS Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	-	-	-	-	-	-	-
Gross Profit	-	0	0	0	0	0	0	-
Operating Income	0	-3	-9	-14	-14	-18	-14	-15
EBITDA	-6	-3	-9	-14	-15	-18	-14	-15
Interest Expense	0	0	0	0	0	0	0	0
Depreciation	-	0	0	0	0	0	0	0
Income Before Tax	-7	-3	-9	-14	-15	-18	-14	-15
Income Tax Expense	0	0	0	0	0	0	-	-
Net Income	-7	-3	-9	-14	-15	-18	-14	-15
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

CNS Pharmaceuticals Inc Quarterly Cash Flow

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-5	-3	-2	-5	-3	-4	-2	-3	-5
Operating Cash Flow	-2	-3	-1	-6	-5	-3	-5	-2	-3
Investing Cash Flow	-	0	-	-	0	0	-	-	0
Financing Cash Flow	2	3	2	12	4	9	4	0	0
Change in Cash	0	0	0	5	0	6	0	-2	-2

CNS Pharmaceuticals Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-7	-3	-9	-14	-15	-18	-14	-15
Operating Cash Flow	0	-3	-7	-13	-10	-14	-17	-13
Investing Cash Flow	0	0	0	0	0	0	0	0
Financing Cash Flow	1	10	14	4	15	4	23	14
Change in Cash	0	6	6	-9	5	-9	5	0

Global Institutional Holdings in CNS Pharmaceuticals Inc

Funds	Holdings
Morgan Stanley - Brokerage Accounts	0%
Stonepine Capital Management Llc	6.02%
Ground Swell Capital, LLC	0%
DRW Securities, LLC	1.9%
Bank of America Corp	0%

See all

Insights on CNS Pharmaceuticals Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, CNSP stock has moved up by 216.4%
NO EFFECT
Against Peers
In the last 1 year, Regeneron Pharmaceuticals, Inc. has given 25.7% return, outperforming this stock by 71.5%
NO EFFECT
Against Peers
In the last 3 years, CNS PHARMACEUTICALS INC has experienced a drawdown of -100.0%, however Alnylam Pharmaceuticals, Inc. resisted the overall trend and outperformed by 92.1%

About CNS Pharmaceuticals Inc

CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, develops anti-cancer drug candidates for the treatment of brain and central nervous system (CNS) tumors. The company's drug candidates include TPI 287 and Berubicin, which are in Phase 2 clinical trial for the treatment of glioblastoma and other CNS malignancies. It has license agreement with Cortice Biosciences, Inc. The company was incorporated in 2017 and is headquartered in Houston, Texas.

Organisation	CNS Pharmaceuticals Inc
Headquarters	2100 West Loop South, Houston, TX, United States, 77027
Industry	Biotechnology
CEO	Mr. Rami Levin M.B.A.
E-voting on shares	Click here to vote

Key Management of CNS Pharmaceuticals Inc

Name	Title
Mr. Rami Levin M.B.A.	President, CEO & Director
Mr. Dylan Wenke M.B.A.	Chief Business Officer

FAQs

What is CNS Pharmaceuticals Inc share price today?

CNS Pharmaceuticals Inc share price today is $7.12 as on May 6, 2026 at 1:29 am IST at the close of the market. CNS Pharmaceuticals Inc share today touched a day high of $7.3 and a low of $5.27.

What is the 52 week high and 52 week low for CNS Pharmaceuticals Inc share?

CNS Pharmaceuticals Inc share touched a 52 week high of $34.8 on May 13, 2025 and a 52 week low of $1.9 on April 22, 2026. CNS Pharmaceuticals Inc stock price today i.e. May 6, 2026 at 1:29 am IST is closed at $7.12,which is 79.54% down from its 52 week high and 274.74% up from its 52 week low.

What is CNS Pharmaceuticals Inc's market capitalisation today?

CNS Pharmaceuticals Inc market capitalisation is $0.00T as on May 6, 2026 at 1:29 am IST.

How to invest in CNS Pharmaceuticals Inc Stock (CNSP) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for CNS Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in CNS Pharmaceuticals Inc Shares that will get you 0.2107 shares as per CNS Pharmaceuticals Inc share price of $7.12 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy CNS Pharmaceuticals Inc Stock (CNSP) from India?

Indian investors can start investing in CNS Pharmaceuticals Inc (CNSP) shares with as little as ₹95.28 or $1 (as of May 6, 2026 at 3:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in CNS Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on May 6, 2026 at 3:42 pm IST). Based on CNS Pharmaceuticals Inc share’s latest price of $7.12 as on May 6, 2026 at 1:29 am IST, you will get 1.4045 shares of CNS Pharmaceuticals Inc. Learn more about fractional shares .

What are the returns that CNS Pharmaceuticals Inc has given to Indian investors in the last 5 years?

CNS Pharmaceuticals Inc stock has given -100% share price returns and 28.83% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?